Global Z-drugs Supply, Demand and Key Producers, 2026-2032
The global Z-drugs market size is expected to reach $ 1479 million by 2032, rising at a market growth of 2.8% CAGR during the forecast period (2026-2032).
Z-drugs are non-benzodiazepine prescription sedative-hypnotics primarily represented by zolpidem, zopiclone, eszopiclone, and zaleplon. Although chemically distinct from conventional benzodiazepines, they mainly produce hypnotic effects by modulating the GABA_A receptor complex and are used to treat difficulty initiating sleep, frequent nocturnal awakening, early awakening, and sleep-maintenance insomnia. Major dosage forms include immediate-release tablets, extended-release tablets, capsules, sublingual tablets, orally disintegrating tablets, and oral sprays. Upstream inputs mainly include zolpidem tartrate, zopiclone, eszopiclone, and zaleplon active pharmaceutical ingredients, together with fillers, disintegrants, coating materials, capsule shells, blister packaging, and other pharmaceutical packaging materials. Downstream customers mainly include hospitals, psychiatric and sleep clinics, primary care institutions, retail pharmacies, pharmaceutical wholesalers, and regulated online prescription platforms. Generic competition is relatively intense in conventional tablets, while extended-release, sublingual, and spray formulations and established branded products retain higher added value, with an overall gross margin generally ranging from approximately 45% to 68%.
From the current market perspective, Z-drugs have developed into a mature market dominated by zolpidem, with zopiclone and eszopiclone representing important secondary segments and zaleplon accounting for a relatively small share. All major active ingredients are exposed to generic competition, and standard tablets are supplied by numerous manufacturers. Regional structures differ: the United States relies mainly on zolpidem and eszopiclone, zopiclone is more widely used in Europe, Canada, and parts of Asia, and China uses zolpidem, zopiclone, and eszopiclone under controlled manufacturing, distribution, and prescribing requirements.
Looking ahead, market development will focus mainly on dosage-form optimization, lower-dose treatment, precision dosing, and medication safety. Standard tablets will continue to account for most volume, while extended-release tablets, sublingual tablets, orally disintegrating tablets, oral sprays, and low-dose products for middle-of-the-night awakening offer greater differentiation. Manufacturers will strengthen risk management relating to next-day impairment, complex sleep behaviors, falls in older patients, and dependence.
Key market drivers include faster-paced lifestyles, psychological stress, population aging, psychiatric comorbidities, and improving recognition of sleep disorders. Z-drugs have long-established clinical use, rapid onset, broad physician familiarity, and widespread generic availability. Their treatment costs are generally lower than those of newer-mechanism medicines such as orexin receptor antagonists, supporting continued use in hospitals, primary care institutions, and retail prescription markets.
The main constraints include risks of tolerance, dependence, misuse, withdrawal, next-day cognitive and motor impairment, and complex sleep behaviors. Many jurisdictions impose controlled-drug rules, prescription-duration limits, and dose restrictions. Cognitive behavioral therapy for insomnia, digital sleep interventions, orexin receptor antagonists, and other new-mechanism treatments will divert some chronic-insomnia patients. Generic competition and reimbursement controls will also continue to reduce average selling prices.
This report studies the global Z-drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Z-drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Z-drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Z-drugs total market, 2021-2032, (USD Million)
Global Z-drugs total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Z-drugs total market, key domestic companies, and share, (USD Million)
Global Z-drugs revenue by player, revenue and market share 2021-2026, (USD Million)
Global Z-drugs total market by Type, CAGR, 2021-2032, (USD Million)
Global Z-drugs total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Z-drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cosette Pharmaceuticals, Sanofi, Sumitomo Pharma, Teva Pharmaceutical Industries, Viatris, Sandoz, Aurobindo Pharma, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Torrent Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Z-drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Z-drugs Market, By Region:
1. How big is the global Z-drugs market?
2. What is the demand of the global Z-drugs market?
3. What is the year over year growth of the global Z-drugs market?
4. What is the total value of the global Z-drugs market?
5. Who are the Major Players in the global Z-drugs market?
6. What are the growth factors driving the market demand?
Z-drugs are non-benzodiazepine prescription sedative-hypnotics primarily represented by zolpidem, zopiclone, eszopiclone, and zaleplon. Although chemically distinct from conventional benzodiazepines, they mainly produce hypnotic effects by modulating the GABA_A receptor complex and are used to treat difficulty initiating sleep, frequent nocturnal awakening, early awakening, and sleep-maintenance insomnia. Major dosage forms include immediate-release tablets, extended-release tablets, capsules, sublingual tablets, orally disintegrating tablets, and oral sprays. Upstream inputs mainly include zolpidem tartrate, zopiclone, eszopiclone, and zaleplon active pharmaceutical ingredients, together with fillers, disintegrants, coating materials, capsule shells, blister packaging, and other pharmaceutical packaging materials. Downstream customers mainly include hospitals, psychiatric and sleep clinics, primary care institutions, retail pharmacies, pharmaceutical wholesalers, and regulated online prescription platforms. Generic competition is relatively intense in conventional tablets, while extended-release, sublingual, and spray formulations and established branded products retain higher added value, with an overall gross margin generally ranging from approximately 45% to 68%.
From the current market perspective, Z-drugs have developed into a mature market dominated by zolpidem, with zopiclone and eszopiclone representing important secondary segments and zaleplon accounting for a relatively small share. All major active ingredients are exposed to generic competition, and standard tablets are supplied by numerous manufacturers. Regional structures differ: the United States relies mainly on zolpidem and eszopiclone, zopiclone is more widely used in Europe, Canada, and parts of Asia, and China uses zolpidem, zopiclone, and eszopiclone under controlled manufacturing, distribution, and prescribing requirements.
Looking ahead, market development will focus mainly on dosage-form optimization, lower-dose treatment, precision dosing, and medication safety. Standard tablets will continue to account for most volume, while extended-release tablets, sublingual tablets, orally disintegrating tablets, oral sprays, and low-dose products for middle-of-the-night awakening offer greater differentiation. Manufacturers will strengthen risk management relating to next-day impairment, complex sleep behaviors, falls in older patients, and dependence.
Key market drivers include faster-paced lifestyles, psychological stress, population aging, psychiatric comorbidities, and improving recognition of sleep disorders. Z-drugs have long-established clinical use, rapid onset, broad physician familiarity, and widespread generic availability. Their treatment costs are generally lower than those of newer-mechanism medicines such as orexin receptor antagonists, supporting continued use in hospitals, primary care institutions, and retail prescription markets.
The main constraints include risks of tolerance, dependence, misuse, withdrawal, next-day cognitive and motor impairment, and complex sleep behaviors. Many jurisdictions impose controlled-drug rules, prescription-duration limits, and dose restrictions. Cognitive behavioral therapy for insomnia, digital sleep interventions, orexin receptor antagonists, and other new-mechanism treatments will divert some chronic-insomnia patients. Generic competition and reimbursement controls will also continue to reduce average selling prices.
This report studies the global Z-drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Z-drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Z-drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Z-drugs total market, 2021-2032, (USD Million)
Global Z-drugs total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Z-drugs total market, key domestic companies, and share, (USD Million)
Global Z-drugs revenue by player, revenue and market share 2021-2026, (USD Million)
Global Z-drugs total market by Type, CAGR, 2021-2032, (USD Million)
Global Z-drugs total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Z-drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cosette Pharmaceuticals, Sanofi, Sumitomo Pharma, Teva Pharmaceutical Industries, Viatris, Sandoz, Aurobindo Pharma, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Torrent Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Z-drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Z-drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Zolpidem
- Zopiclone
- Eszopiclone
- Zaleplon
- Tablets
- Capsules
- Other
- Originator Drugs
- Generic Drugs
- Hospitals
- Clinics
- Other
- Cosette Pharmaceuticals
- Sanofi
- Sumitomo Pharma
- Teva Pharmaceutical Industries
- Viatris
- Sandoz
- Aurobindo Pharma
- Sun Pharmaceutical Industries
- Dr. Reddy's Laboratories
- Torrent Pharmaceuticals
- Lupin
- Jiangsu Nhwa Pharmaceutical
- Shanghai Pharmaceuticals
- Qilu Pharmaceutical
- Chengdu Kanghong Pharmaceutical Group
1. How big is the global Z-drugs market?
2. What is the demand of the global Z-drugs market?
3. What is the year over year growth of the global Z-drugs market?
4. What is the total value of the global Z-drugs market?
5. Who are the Major Players in the global Z-drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Z-drugs Introduction
1.2 World Z-drugs Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Z-drugs Total Market by Region (by Headquarter Location)
1.3.1 World Z-drugs Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Z-drugs Revenue (2021-2032)
1.3.3 China Based Company Z-drugs Revenue (2021-2032)
1.3.4 Europe Based Company Z-drugs Revenue (2021-2032)
1.3.5 Japan Based Company Z-drugs Revenue (2021-2032)
1.3.6 South Korea Based Company Z-drugs Revenue (2021-2032)
1.3.7 ASEAN Based Company Z-drugs Revenue (2021-2032)
1.3.8 India Based Company Z-drugs Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Z-drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Z-drugs Consumption Value (2021-2032)
2.2 World Z-drugs Consumption Value by Region
2.2.1 World Z-drugs Consumption Value by Region (2021-2026)
2.2.2 World Z-drugs Consumption Value Forecast by Region (2027-2032)
2.3 United States Z-drugs Consumption Value (2021-2032)
2.4 China Z-drugs Consumption Value (2021-2032)
2.5 Europe Z-drugs Consumption Value (2021-2032)
2.6 Japan Z-drugs Consumption Value (2021-2032)
2.7 South Korea Z-drugs Consumption Value (2021-2032)
2.8 ASEAN Z-drugs Consumption Value (2021-2032)
2.9 India Z-drugs Consumption Value (2021-2032)
3 WORLD Z-DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Z-drugs Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Z-drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Z-drugs in 2025
3.2.3 Global Concentration Ratios (CR8) for Z-drugs in 2025
3.3 Z-drugs Company Evaluation Quadrant
3.4 Z-drugs Market: Overall Company Footprint Analysis
3.4.1 Z-drugs Market: Region Footprint
3.4.2 Z-drugs Market: Company Product Type Footprint
3.4.3 Z-drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Z-drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Z-drugs Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Z-drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Z-drugs Consumption Value Comparison
4.2.1 United States VS China: Z-drugs Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Z-drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Z-drugs Companies and Market Share, 2021-2026
4.3.1 United States Based Z-drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Z-drugs Revenue, (2021-2026)
4.4 China Based Companies Z-drugs Revenue and Market Share, 2021-2026
4.4.1 China Based Z-drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Z-drugs Revenue, (2021-2026)
4.5 Rest of World Based Z-drugs Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Z-drugs Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Z-drugs Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Z-drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Zolpidem
5.2.2 Zopiclone
5.2.3 Eszopiclone
5.2.4 Zaleplon
5.3 Market Segment by Type
5.3.1 World Z-drugs Market Size by Type (2021-2026)
5.3.2 World Z-drugs Market Size by Type (2027-2032)
5.3.3 World Z-drugs Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Z-drugs Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Tablets
6.2.2 Capsules
6.2.3 Other
6.3 Market Segment by Dosage Form
6.3.1 World Z-drugs Market Size by Dosage Form (2021-2026)
6.3.2 World Z-drugs Market Size by Dosage Form (2027-2032)
6.3.3 World Z-drugs Market Size Market Share by Dosage Form (2027-2032)
7 MARKET ANALYSIS BY PRODUCT STATUS
7.1 World Z-drugs Market Size Overview by Product Status: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Status
7.2.1 Originator Drugs
7.2.2 Generic Drugs
7.3 Market Segment by Product Status
7.3.1 World Z-drugs Market Size by Product Status (2021-2026)
7.3.2 World Z-drugs Market Size by Product Status (2027-2032)
7.3.3 World Z-drugs Market Size Market Share by Product Status (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Z-drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Z-drugs Market Size by Application (2021-2026)
8.3.2 World Z-drugs Market Size by Application (2027-2032)
8.3.3 World Z-drugs Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Cosette Pharmaceuticals
9.1.1 Cosette Pharmaceuticals Details
9.1.2 Cosette Pharmaceuticals Major Business
9.1.3 Cosette Pharmaceuticals Z-drugs Product and Services
9.1.4 Cosette Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Cosette Pharmaceuticals Recent Developments/Updates
9.1.6 Cosette Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Sanofi
9.2.1 Sanofi Details
9.2.2 Sanofi Major Business
9.2.3 Sanofi Z-drugs Product and Services
9.2.4 Sanofi Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Sanofi Recent Developments/Updates
9.2.6 Sanofi Competitive Strengths & Weaknesses
9.3 Sumitomo Pharma
9.3.1 Sumitomo Pharma Details
9.3.2 Sumitomo Pharma Major Business
9.3.3 Sumitomo Pharma Z-drugs Product and Services
9.3.4 Sumitomo Pharma Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Sumitomo Pharma Recent Developments/Updates
9.3.6 Sumitomo Pharma Competitive Strengths & Weaknesses
9.4 Teva Pharmaceutical Industries
9.4.1 Teva Pharmaceutical Industries Details
9.4.2 Teva Pharmaceutical Industries Major Business
9.4.3 Teva Pharmaceutical Industries Z-drugs Product and Services
9.4.4 Teva Pharmaceutical Industries Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.4.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.5 Viatris
9.5.1 Viatris Details
9.5.2 Viatris Major Business
9.5.3 Viatris Z-drugs Product and Services
9.5.4 Viatris Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Viatris Recent Developments/Updates
9.5.6 Viatris Competitive Strengths & Weaknesses
9.6 Sandoz
9.6.1 Sandoz Details
9.6.2 Sandoz Major Business
9.6.3 Sandoz Z-drugs Product and Services
9.6.4 Sandoz Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Sandoz Recent Developments/Updates
9.6.6 Sandoz Competitive Strengths & Weaknesses
9.7 Aurobindo Pharma
9.7.1 Aurobindo Pharma Details
9.7.2 Aurobindo Pharma Major Business
9.7.3 Aurobindo Pharma Z-drugs Product and Services
9.7.4 Aurobindo Pharma Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Aurobindo Pharma Recent Developments/Updates
9.7.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.8 Sun Pharmaceutical Industries
9.8.1 Sun Pharmaceutical Industries Details
9.8.2 Sun Pharmaceutical Industries Major Business
9.8.3 Sun Pharmaceutical Industries Z-drugs Product and Services
9.8.4 Sun Pharmaceutical Industries Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.8.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.9 Dr. Reddy's Laboratories
9.9.1 Dr. Reddy's Laboratories Details
9.9.2 Dr. Reddy's Laboratories Major Business
9.9.3 Dr. Reddy's Laboratories Z-drugs Product and Services
9.9.4 Dr. Reddy's Laboratories Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Dr. Reddy's Laboratories Recent Developments/Updates
9.9.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
9.10 Torrent Pharmaceuticals
9.10.1 Torrent Pharmaceuticals Details
9.10.2 Torrent Pharmaceuticals Major Business
9.10.3 Torrent Pharmaceuticals Z-drugs Product and Services
9.10.4 Torrent Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Torrent Pharmaceuticals Recent Developments/Updates
9.10.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
9.11 Lupin
9.11.1 Lupin Details
9.11.2 Lupin Major Business
9.11.3 Lupin Z-drugs Product and Services
9.11.4 Lupin Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Lupin Recent Developments/Updates
9.11.6 Lupin Competitive Strengths & Weaknesses
9.12 Jiangsu Nhwa Pharmaceutical
9.12.1 Jiangsu Nhwa Pharmaceutical Details
9.12.2 Jiangsu Nhwa Pharmaceutical Major Business
9.12.3 Jiangsu Nhwa Pharmaceutical Z-drugs Product and Services
9.12.4 Jiangsu Nhwa Pharmaceutical Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
9.12.6 Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
9.13 Shanghai Pharmaceuticals
9.13.1 Shanghai Pharmaceuticals Details
9.13.2 Shanghai Pharmaceuticals Major Business
9.13.3 Shanghai Pharmaceuticals Z-drugs Product and Services
9.13.4 Shanghai Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Shanghai Pharmaceuticals Recent Developments/Updates
9.13.6 Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
9.14 Qilu Pharmaceutical
9.14.1 Qilu Pharmaceutical Details
9.14.2 Qilu Pharmaceutical Major Business
9.14.3 Qilu Pharmaceutical Z-drugs Product and Services
9.14.4 Qilu Pharmaceutical Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Qilu Pharmaceutical Recent Developments/Updates
9.14.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
9.15 Chengdu Kanghong Pharmaceutical Group
9.15.1 Chengdu Kanghong Pharmaceutical Group Details
9.15.2 Chengdu Kanghong Pharmaceutical Group Major Business
9.15.3 Chengdu Kanghong Pharmaceutical Group Z-drugs Product and Services
9.15.4 Chengdu Kanghong Pharmaceutical Group Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
9.15.6 Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Z-drugs Industry Chain
10.2 Z-drugs Upstream Analysis
10.3 Z-drugs Midstream Analysis
10.4 Z-drugs Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Z-drugs Introduction
1.2 World Z-drugs Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Z-drugs Total Market by Region (by Headquarter Location)
1.3.1 World Z-drugs Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Z-drugs Revenue (2021-2032)
1.3.3 China Based Company Z-drugs Revenue (2021-2032)
1.3.4 Europe Based Company Z-drugs Revenue (2021-2032)
1.3.5 Japan Based Company Z-drugs Revenue (2021-2032)
1.3.6 South Korea Based Company Z-drugs Revenue (2021-2032)
1.3.7 ASEAN Based Company Z-drugs Revenue (2021-2032)
1.3.8 India Based Company Z-drugs Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Z-drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Z-drugs Consumption Value (2021-2032)
2.2 World Z-drugs Consumption Value by Region
2.2.1 World Z-drugs Consumption Value by Region (2021-2026)
2.2.2 World Z-drugs Consumption Value Forecast by Region (2027-2032)
2.3 United States Z-drugs Consumption Value (2021-2032)
2.4 China Z-drugs Consumption Value (2021-2032)
2.5 Europe Z-drugs Consumption Value (2021-2032)
2.6 Japan Z-drugs Consumption Value (2021-2032)
2.7 South Korea Z-drugs Consumption Value (2021-2032)
2.8 ASEAN Z-drugs Consumption Value (2021-2032)
2.9 India Z-drugs Consumption Value (2021-2032)
3 WORLD Z-DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Z-drugs Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Z-drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Z-drugs in 2025
3.2.3 Global Concentration Ratios (CR8) for Z-drugs in 2025
3.3 Z-drugs Company Evaluation Quadrant
3.4 Z-drugs Market: Overall Company Footprint Analysis
3.4.1 Z-drugs Market: Region Footprint
3.4.2 Z-drugs Market: Company Product Type Footprint
3.4.3 Z-drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Z-drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Z-drugs Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Z-drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Z-drugs Consumption Value Comparison
4.2.1 United States VS China: Z-drugs Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Z-drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Z-drugs Companies and Market Share, 2021-2026
4.3.1 United States Based Z-drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Z-drugs Revenue, (2021-2026)
4.4 China Based Companies Z-drugs Revenue and Market Share, 2021-2026
4.4.1 China Based Z-drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Z-drugs Revenue, (2021-2026)
4.5 Rest of World Based Z-drugs Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Z-drugs Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Z-drugs Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Z-drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Zolpidem
5.2.2 Zopiclone
5.2.3 Eszopiclone
5.2.4 Zaleplon
5.3 Market Segment by Type
5.3.1 World Z-drugs Market Size by Type (2021-2026)
5.3.2 World Z-drugs Market Size by Type (2027-2032)
5.3.3 World Z-drugs Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Z-drugs Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Tablets
6.2.2 Capsules
6.2.3 Other
6.3 Market Segment by Dosage Form
6.3.1 World Z-drugs Market Size by Dosage Form (2021-2026)
6.3.2 World Z-drugs Market Size by Dosage Form (2027-2032)
6.3.3 World Z-drugs Market Size Market Share by Dosage Form (2027-2032)
7 MARKET ANALYSIS BY PRODUCT STATUS
7.1 World Z-drugs Market Size Overview by Product Status: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Status
7.2.1 Originator Drugs
7.2.2 Generic Drugs
7.3 Market Segment by Product Status
7.3.1 World Z-drugs Market Size by Product Status (2021-2026)
7.3.2 World Z-drugs Market Size by Product Status (2027-2032)
7.3.3 World Z-drugs Market Size Market Share by Product Status (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Z-drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Z-drugs Market Size by Application (2021-2026)
8.3.2 World Z-drugs Market Size by Application (2027-2032)
8.3.3 World Z-drugs Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Cosette Pharmaceuticals
9.1.1 Cosette Pharmaceuticals Details
9.1.2 Cosette Pharmaceuticals Major Business
9.1.3 Cosette Pharmaceuticals Z-drugs Product and Services
9.1.4 Cosette Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Cosette Pharmaceuticals Recent Developments/Updates
9.1.6 Cosette Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Sanofi
9.2.1 Sanofi Details
9.2.2 Sanofi Major Business
9.2.3 Sanofi Z-drugs Product and Services
9.2.4 Sanofi Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Sanofi Recent Developments/Updates
9.2.6 Sanofi Competitive Strengths & Weaknesses
9.3 Sumitomo Pharma
9.3.1 Sumitomo Pharma Details
9.3.2 Sumitomo Pharma Major Business
9.3.3 Sumitomo Pharma Z-drugs Product and Services
9.3.4 Sumitomo Pharma Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Sumitomo Pharma Recent Developments/Updates
9.3.6 Sumitomo Pharma Competitive Strengths & Weaknesses
9.4 Teva Pharmaceutical Industries
9.4.1 Teva Pharmaceutical Industries Details
9.4.2 Teva Pharmaceutical Industries Major Business
9.4.3 Teva Pharmaceutical Industries Z-drugs Product and Services
9.4.4 Teva Pharmaceutical Industries Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.4.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.5 Viatris
9.5.1 Viatris Details
9.5.2 Viatris Major Business
9.5.3 Viatris Z-drugs Product and Services
9.5.4 Viatris Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Viatris Recent Developments/Updates
9.5.6 Viatris Competitive Strengths & Weaknesses
9.6 Sandoz
9.6.1 Sandoz Details
9.6.2 Sandoz Major Business
9.6.3 Sandoz Z-drugs Product and Services
9.6.4 Sandoz Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Sandoz Recent Developments/Updates
9.6.6 Sandoz Competitive Strengths & Weaknesses
9.7 Aurobindo Pharma
9.7.1 Aurobindo Pharma Details
9.7.2 Aurobindo Pharma Major Business
9.7.3 Aurobindo Pharma Z-drugs Product and Services
9.7.4 Aurobindo Pharma Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Aurobindo Pharma Recent Developments/Updates
9.7.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.8 Sun Pharmaceutical Industries
9.8.1 Sun Pharmaceutical Industries Details
9.8.2 Sun Pharmaceutical Industries Major Business
9.8.3 Sun Pharmaceutical Industries Z-drugs Product and Services
9.8.4 Sun Pharmaceutical Industries Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.8.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.9 Dr. Reddy's Laboratories
9.9.1 Dr. Reddy's Laboratories Details
9.9.2 Dr. Reddy's Laboratories Major Business
9.9.3 Dr. Reddy's Laboratories Z-drugs Product and Services
9.9.4 Dr. Reddy's Laboratories Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Dr. Reddy's Laboratories Recent Developments/Updates
9.9.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
9.10 Torrent Pharmaceuticals
9.10.1 Torrent Pharmaceuticals Details
9.10.2 Torrent Pharmaceuticals Major Business
9.10.3 Torrent Pharmaceuticals Z-drugs Product and Services
9.10.4 Torrent Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Torrent Pharmaceuticals Recent Developments/Updates
9.10.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
9.11 Lupin
9.11.1 Lupin Details
9.11.2 Lupin Major Business
9.11.3 Lupin Z-drugs Product and Services
9.11.4 Lupin Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Lupin Recent Developments/Updates
9.11.6 Lupin Competitive Strengths & Weaknesses
9.12 Jiangsu Nhwa Pharmaceutical
9.12.1 Jiangsu Nhwa Pharmaceutical Details
9.12.2 Jiangsu Nhwa Pharmaceutical Major Business
9.12.3 Jiangsu Nhwa Pharmaceutical Z-drugs Product and Services
9.12.4 Jiangsu Nhwa Pharmaceutical Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
9.12.6 Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
9.13 Shanghai Pharmaceuticals
9.13.1 Shanghai Pharmaceuticals Details
9.13.2 Shanghai Pharmaceuticals Major Business
9.13.3 Shanghai Pharmaceuticals Z-drugs Product and Services
9.13.4 Shanghai Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Shanghai Pharmaceuticals Recent Developments/Updates
9.13.6 Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
9.14 Qilu Pharmaceutical
9.14.1 Qilu Pharmaceutical Details
9.14.2 Qilu Pharmaceutical Major Business
9.14.3 Qilu Pharmaceutical Z-drugs Product and Services
9.14.4 Qilu Pharmaceutical Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Qilu Pharmaceutical Recent Developments/Updates
9.14.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
9.15 Chengdu Kanghong Pharmaceutical Group
9.15.1 Chengdu Kanghong Pharmaceutical Group Details
9.15.2 Chengdu Kanghong Pharmaceutical Group Major Business
9.15.3 Chengdu Kanghong Pharmaceutical Group Z-drugs Product and Services
9.15.4 Chengdu Kanghong Pharmaceutical Group Z-drugs Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
9.15.6 Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Z-drugs Industry Chain
10.2 Z-drugs Upstream Analysis
10.3 Z-drugs Midstream Analysis
10.4 Z-drugs Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Z-drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Z-drugs Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Z-drugs Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Z-drugs Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Z-drugs Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Z-drugs Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Z-drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Z-drugs Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Z-drugs Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Z-drugs Players in 2025
Table 12. World Z-drugs Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Z-drugs Company Evaluation Quadrant
Table 14. Head Office of Key Z-drugs Players
Table 15. Z-drugs Market: Company Product Type Footprint
Table 16. Z-drugs Market: Company Product Application Footprint
Table 17. Z-drugs Mergers & Acquisitions Activity
Table 18. United States VS China Z-drugs Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Z-drugs Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Z-drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Z-drugs Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Z-drugs Revenue Market Share (2021-2026)
Table 23. China Based Z-drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Z-drugs Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Z-drugs Revenue Market Share (2021-2026)
Table 26. Rest of World Based Z-drugs Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Z-drugs Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Z-drugs Revenue Market Share (2021-2026)
Table 29. World Z-drugs Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Z-drugs Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Z-drugs Market Size by Type (2027-2032) & (USD Million)
Table 32. World Z-drugs Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 33. World Z-drugs Market Size Value by Dosage Form (2021-2026) & (USD Million)
Table 34. World Z-drugs Market Size by Dosage Form (2027-2032) & (USD Million)
Table 35. World Z-drugs Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Table 36. World Z-drugs Market Size Value by Product Status (2021-2026) & (USD Million)
Table 37. World Z-drugs Market Size by Product Status (2027-2032) & (USD Million)
Table 38. World Z-drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Z-drugs Market Size by Application (2021-2026) & (USD Million)
Table 40. World Z-drugs Market Size by Application (2027-2032) & (USD Million)
Table 41. Cosette Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 42. Cosette Pharmaceuticals Major Business
Table 43. Cosette Pharmaceuticals Z-drugs Product and Services
Table 44. Cosette Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Cosette Pharmaceuticals Recent Developments/Updates
Table 46. Cosette Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Sanofi Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi Major Business
Table 49. Sanofi Z-drugs Product and Services
Table 50. Sanofi Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Sanofi Recent Developments/Updates
Table 52. Sanofi Competitive Strengths & Weaknesses
Table 53. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Sumitomo Pharma Major Business
Table 55. Sumitomo Pharma Z-drugs Product and Services
Table 56. Sumitomo Pharma Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sumitomo Pharma Recent Developments/Updates
Table 58. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 59. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 60. Teva Pharmaceutical Industries Major Business
Table 61. Teva Pharmaceutical Industries Z-drugs Product and Services
Table 62. Teva Pharmaceutical Industries Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Teva Pharmaceutical Industries Recent Developments/Updates
Table 64. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 65. Viatris Basic Information, Manufacturing Base and Competitors
Table 66. Viatris Major Business
Table 67. Viatris Z-drugs Product and Services
Table 68. Viatris Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Viatris Recent Developments/Updates
Table 70. Viatris Competitive Strengths & Weaknesses
Table 71. Sandoz Basic Information, Manufacturing Base and Competitors
Table 72. Sandoz Major Business
Table 73. Sandoz Z-drugs Product and Services
Table 74. Sandoz Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Sandoz Recent Developments/Updates
Table 76. Sandoz Competitive Strengths & Weaknesses
Table 77. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 78. Aurobindo Pharma Major Business
Table 79. Aurobindo Pharma Z-drugs Product and Services
Table 80. Aurobindo Pharma Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Aurobindo Pharma Recent Developments/Updates
Table 82. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 83. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 84. Sun Pharmaceutical Industries Major Business
Table 85. Sun Pharmaceutical Industries Z-drugs Product and Services
Table 86. Sun Pharmaceutical Industries Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Sun Pharmaceutical Industries Recent Developments/Updates
Table 88. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 89. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 90. Dr. Reddy's Laboratories Major Business
Table 91. Dr. Reddy's Laboratories Z-drugs Product and Services
Table 92. Dr. Reddy's Laboratories Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Dr. Reddy's Laboratories Recent Developments/Updates
Table 94. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
Table 95. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 96. Torrent Pharmaceuticals Major Business
Table 97. Torrent Pharmaceuticals Z-drugs Product and Services
Table 98. Torrent Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Torrent Pharmaceuticals Recent Developments/Updates
Table 100. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 101. Lupin Basic Information, Manufacturing Base and Competitors
Table 102. Lupin Major Business
Table 103. Lupin Z-drugs Product and Services
Table 104. Lupin Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Lupin Recent Developments/Updates
Table 106. Lupin Competitive Strengths & Weaknesses
Table 107. Jiangsu Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 108. Jiangsu Nhwa Pharmaceutical Major Business
Table 109. Jiangsu Nhwa Pharmaceutical Z-drugs Product and Services
Table 110. Jiangsu Nhwa Pharmaceutical Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 112. Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
Table 113. Shanghai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 114. Shanghai Pharmaceuticals Major Business
Table 115. Shanghai Pharmaceuticals Z-drugs Product and Services
Table 116. Shanghai Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Shanghai Pharmaceuticals Recent Developments/Updates
Table 118. Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
Table 119. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 120. Qilu Pharmaceutical Major Business
Table 121. Qilu Pharmaceutical Z-drugs Product and Services
Table 122. Qilu Pharmaceutical Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Qilu Pharmaceutical Recent Developments/Updates
Table 124. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 125. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 126. Chengdu Kanghong Pharmaceutical Group Major Business
Table 127. Chengdu Kanghong Pharmaceutical Group Z-drugs Product and Services
Table 128. Chengdu Kanghong Pharmaceutical Group Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 130. Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
Table 131. Global Key Players of Z-drugs Upstream (Raw Materials)
Table 132. Global Z-drugs Typical Customers
Table 1. World Z-drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Z-drugs Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Z-drugs Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Z-drugs Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Z-drugs Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Z-drugs Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Z-drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Z-drugs Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Z-drugs Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Z-drugs Players in 2025
Table 12. World Z-drugs Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Z-drugs Company Evaluation Quadrant
Table 14. Head Office of Key Z-drugs Players
Table 15. Z-drugs Market: Company Product Type Footprint
Table 16. Z-drugs Market: Company Product Application Footprint
Table 17. Z-drugs Mergers & Acquisitions Activity
Table 18. United States VS China Z-drugs Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Z-drugs Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Z-drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Z-drugs Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Z-drugs Revenue Market Share (2021-2026)
Table 23. China Based Z-drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Z-drugs Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Z-drugs Revenue Market Share (2021-2026)
Table 26. Rest of World Based Z-drugs Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Z-drugs Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Z-drugs Revenue Market Share (2021-2026)
Table 29. World Z-drugs Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Z-drugs Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Z-drugs Market Size by Type (2027-2032) & (USD Million)
Table 32. World Z-drugs Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 33. World Z-drugs Market Size Value by Dosage Form (2021-2026) & (USD Million)
Table 34. World Z-drugs Market Size by Dosage Form (2027-2032) & (USD Million)
Table 35. World Z-drugs Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Table 36. World Z-drugs Market Size Value by Product Status (2021-2026) & (USD Million)
Table 37. World Z-drugs Market Size by Product Status (2027-2032) & (USD Million)
Table 38. World Z-drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Z-drugs Market Size by Application (2021-2026) & (USD Million)
Table 40. World Z-drugs Market Size by Application (2027-2032) & (USD Million)
Table 41. Cosette Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 42. Cosette Pharmaceuticals Major Business
Table 43. Cosette Pharmaceuticals Z-drugs Product and Services
Table 44. Cosette Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Cosette Pharmaceuticals Recent Developments/Updates
Table 46. Cosette Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Sanofi Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi Major Business
Table 49. Sanofi Z-drugs Product and Services
Table 50. Sanofi Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Sanofi Recent Developments/Updates
Table 52. Sanofi Competitive Strengths & Weaknesses
Table 53. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Sumitomo Pharma Major Business
Table 55. Sumitomo Pharma Z-drugs Product and Services
Table 56. Sumitomo Pharma Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sumitomo Pharma Recent Developments/Updates
Table 58. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 59. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 60. Teva Pharmaceutical Industries Major Business
Table 61. Teva Pharmaceutical Industries Z-drugs Product and Services
Table 62. Teva Pharmaceutical Industries Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Teva Pharmaceutical Industries Recent Developments/Updates
Table 64. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 65. Viatris Basic Information, Manufacturing Base and Competitors
Table 66. Viatris Major Business
Table 67. Viatris Z-drugs Product and Services
Table 68. Viatris Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Viatris Recent Developments/Updates
Table 70. Viatris Competitive Strengths & Weaknesses
Table 71. Sandoz Basic Information, Manufacturing Base and Competitors
Table 72. Sandoz Major Business
Table 73. Sandoz Z-drugs Product and Services
Table 74. Sandoz Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Sandoz Recent Developments/Updates
Table 76. Sandoz Competitive Strengths & Weaknesses
Table 77. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 78. Aurobindo Pharma Major Business
Table 79. Aurobindo Pharma Z-drugs Product and Services
Table 80. Aurobindo Pharma Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Aurobindo Pharma Recent Developments/Updates
Table 82. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 83. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 84. Sun Pharmaceutical Industries Major Business
Table 85. Sun Pharmaceutical Industries Z-drugs Product and Services
Table 86. Sun Pharmaceutical Industries Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Sun Pharmaceutical Industries Recent Developments/Updates
Table 88. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 89. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 90. Dr. Reddy's Laboratories Major Business
Table 91. Dr. Reddy's Laboratories Z-drugs Product and Services
Table 92. Dr. Reddy's Laboratories Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Dr. Reddy's Laboratories Recent Developments/Updates
Table 94. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
Table 95. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 96. Torrent Pharmaceuticals Major Business
Table 97. Torrent Pharmaceuticals Z-drugs Product and Services
Table 98. Torrent Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Torrent Pharmaceuticals Recent Developments/Updates
Table 100. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 101. Lupin Basic Information, Manufacturing Base and Competitors
Table 102. Lupin Major Business
Table 103. Lupin Z-drugs Product and Services
Table 104. Lupin Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Lupin Recent Developments/Updates
Table 106. Lupin Competitive Strengths & Weaknesses
Table 107. Jiangsu Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 108. Jiangsu Nhwa Pharmaceutical Major Business
Table 109. Jiangsu Nhwa Pharmaceutical Z-drugs Product and Services
Table 110. Jiangsu Nhwa Pharmaceutical Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 112. Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
Table 113. Shanghai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 114. Shanghai Pharmaceuticals Major Business
Table 115. Shanghai Pharmaceuticals Z-drugs Product and Services
Table 116. Shanghai Pharmaceuticals Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Shanghai Pharmaceuticals Recent Developments/Updates
Table 118. Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
Table 119. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 120. Qilu Pharmaceutical Major Business
Table 121. Qilu Pharmaceutical Z-drugs Product and Services
Table 122. Qilu Pharmaceutical Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Qilu Pharmaceutical Recent Developments/Updates
Table 124. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 125. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 126. Chengdu Kanghong Pharmaceutical Group Major Business
Table 127. Chengdu Kanghong Pharmaceutical Group Z-drugs Product and Services
Table 128. Chengdu Kanghong Pharmaceutical Group Z-drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 130. Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
Table 131. Global Key Players of Z-drugs Upstream (Raw Materials)
Table 132. Global Z-drugs Typical Customers
LIST OF FIGURES
Figure 1. Z-drugs Picture
Figure 2. World Z-drugs Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Z-drugs Total Revenue (2021-2032) & (USD Million)
Figure 4. World Z-drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Z-drugs Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 13. Z-drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 16. World Z-drugs Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 18. China Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 23. India Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Z-drugs by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Z-drugs Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Z-drugs Markets in 2025
Figure 27. United States VS China: Z-drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Z-drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Z-drugs Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Z-drugs Market Size Market Share by Type in 2025
Figure 31. Zolpidem
Figure 32. Zopiclone
Figure 33. Eszopiclone
Figure 34. Zaleplon
Figure 35. World Z-drugs Market Size Market Share by Type (2021-2032)
Figure 36. World Z-drugs Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 37. World Z-drugs Market Size Market Share by Dosage Form in 2025
Figure 38.Tablets
Figure 39. Capsules
Figure 40. Other
Figure 41. World Z-drugs Market Size Market Share by Dosage Form (2021-2032)
Figure 42. World Z-drugs Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Figure 43. World Z-drugs Market Size Market Share by Product Status in 2025
Figure 44. Originator Drugs
Figure 45. Generic Drugs
Figure 46. World Z-drugs Market Size Market Share by Product Status (2021-2032)
Figure 47. World Z-drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Z-drugs Market Size Market Share by Application in 2025
Figure 49. Hospitals
Figure 50. Clinics
Figure 51. Other
Figure 52. World Z-drugs Market Size Market Share by Application (2021-2032)
Figure 53. Z-drugs Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Z-drugs Picture
Figure 2. World Z-drugs Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Z-drugs Total Revenue (2021-2032) & (USD Million)
Figure 4. World Z-drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Z-drugs Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Z-drugs Revenue (2021-2032) & (USD Million)
Figure 13. Z-drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 16. World Z-drugs Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 18. China Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 23. India Z-drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Z-drugs by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Z-drugs Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Z-drugs Markets in 2025
Figure 27. United States VS China: Z-drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Z-drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Z-drugs Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Z-drugs Market Size Market Share by Type in 2025
Figure 31. Zolpidem
Figure 32. Zopiclone
Figure 33. Eszopiclone
Figure 34. Zaleplon
Figure 35. World Z-drugs Market Size Market Share by Type (2021-2032)
Figure 36. World Z-drugs Market Size by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 37. World Z-drugs Market Size Market Share by Dosage Form in 2025
Figure 38.Tablets
Figure 39. Capsules
Figure 40. Other
Figure 41. World Z-drugs Market Size Market Share by Dosage Form (2021-2032)
Figure 42. World Z-drugs Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Figure 43. World Z-drugs Market Size Market Share by Product Status in 2025
Figure 44. Originator Drugs
Figure 45. Generic Drugs
Figure 46. World Z-drugs Market Size Market Share by Product Status (2021-2032)
Figure 47. World Z-drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Z-drugs Market Size Market Share by Application in 2025
Figure 49. Hospitals
Figure 50. Clinics
Figure 51. Other
Figure 52. World Z-drugs Market Size Market Share by Application (2021-2032)
Figure 53. Z-drugs Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
